Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Lighthouse Biosciences is a molecular diagnostics company that specializes in the development of rapid, portable, and highly sensitive biosensor technologies for pathogen detection. Spun out of Michigan State University, the company's core platform utilizes Surface Acoustic Wave (SAW) technology to identify specific DNA or RNA sequences in environmental, food, and clinical samples. Their flagship "lab-on-a-chip" products are designed to provide results in minutes, significantly reducing the turnaround time compared to traditional culture-based methods. The company primarily targets applications in food safety, water quality monitoring, and clinical diagnostics for infectious diseases. By eliminating the need for complex sample preparation and PCR amplification, Lighthouse Biosciences offers a cost-effective solution for point-of-care and field-based testing.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Lighthouse Biosciences.